Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
Best GLP-1 for Fastest Weight Loss in 2026
By The RX Index Editorial Team · Last verified:
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers.
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
If you want the fastest weight loss a GLP-1 medication can give you, here’s the short version: for most people starting fresh, the best GLP-1 for fastest weight loss is Zepbound (tirzepatide). In the only head-to-head trial against standard Wegovy, people on Zepbound lost about 20% of their body weight in 72 weeks — versus about 14% on Wegovy. In plain numbers, that’s roughly 50 pounds versus 33.
But there’s a twist most pages still get wrong, and it changes the answer for a lot of people. That famous “Zepbound wins” trial used standard Wegovy dosing — not the newer, stronger Wegovy HD that arrived in 2026. By its own trial, Wegovy HD nearly matches Zepbound. So the honest 2026 answer isn’t “one drug wins forever.” Zepbound has the clearest head-to-head win, Wegovy HD is a serious challenger, and which one is right for you comes down to a few simple things: shot or pill, whether you already take Wegovy, and what your insurance will cover.
Quick pick: which one fits you?
| If this is you… | Start here | Why |
|---|---|---|
| You want the strongest result and you’re okay with a weekly shot | Zepbound (tirzepatide) | Best head-to-head result vs standard Wegovy |
| You already take Wegovy 2.4 mg and want more | Wegovy HD (7.2 mg) | A higher-dose next step, not a starting dose |
| You want a pill with the strongest data | Wegovy pill (oral semaglutide) | ~17% average loss; stricter dosing rules |
| You want the easiest pill routine | Foundayo (orforglipron) | Take it any time, with or without food |
| You heard retatrutide is the strongest | Not available yet | Still in trials — don’t buy “research” versions |
The fastest way to find out which of these you actually qualify for — and what your insurance will cover — is a quick eligibility check. Ro carries Zepbound, both Wegovy options, and Foundayo, and its team handles the insurance paperwork for you.
Check your eligibility and insurance coverage for FDA-approved GLP-1s with Ro → (sponsored affiliate link, opens in a new tab)(sponsored) · Get started for $39 the first month, then as low as $74/month with an annual plan paid upfront. Medication is billed separately.
What is the best GLP-1 for fastest weight loss? Our verified scorecard
The fastest GLP-1 for you is the strongest one you can actually start, afford, and stick with. This is the one table that pulls together what usually takes five tabs to find: how much weight each option produced in its trial, whether a new patient can start it today, and what it costs in cash. Everything here is sourced, and we re-check it monthly.
| # | GLP-1 option | Best for (fastest verdict) | Avg weight loss in trial | New patient can start? | Cash price (starting) |
|---|---|---|---|---|---|
| 1 | Zepbound / tirzepatide (weekly shot) | Most people who want the strongest proven result | ~21% (20.9% at 15 mg; 20.2% vs Wegovy’s 13.7% head-to-head) | Yes | KwikPen $299 first month, then $399–$449/mo |
| 2 | Wegovy HD / semaglutide 7.2 mg (weekly shot) | People already on Wegovy 2.4 mg who need more | ~21% (20.7% completers; 18.8% ITT) | Only after 4+ weeks on Wegovy 2.4 mg | ~$399/mo |
| 3 | Wegovy / semaglutide 2.4 mg (weekly shot) | When insurance, heart-risk benefit, or teen use matters most | ~15% over 68 weeks | Yes | $199/mo first month, then $199–$399 |
| 4 | Wegovy pill / oral semaglutide 25 mg | The strongest pill by the numbers | ~17% (~14% counting everyone) | Yes | $149/mo first month, then $199–$299 |
| 5 | Foundayo / orforglipron (daily pill) | Easiest pill routine | ~11–12% (~27 lb at top dose) | Yes | $149/mo first month, then $199–$299 |
| — | Retatrutide (in trials only) | Strongest future option — can’t buy it | ~28% at 80 weeks (investigational) | No — investigational | No legitimate retail price |
Sources: SURMOUNT-5 and SURMOUNT-1 for Zepbound; STEP UP for Wegovy HD; STEP program for standard Wegovy; OASIS-4 for the Wegovy pill; ATTAIN-1 for Foundayo; TRIUMPH-1 for retatrutide; Ro and NovoCare pricing pages. Prices vary by dose, pharmacy, and current offers — confirm before you commit.
How we scored “fastest”
We weighted it mostly on how much weight each drug produced in its trial (because that’s what people usually mean by “fastest”), then on whether you can start it now, whether it’s FDA-approved for weight loss, the price, and how easy it is to take. This is our editorial framework, built on verified facts. It isn’t medical advice, and it can’t predict your personal result.
How strong is each comparison, really?
Not every “X beats Y” claim is built on the same evidence. Here’s the honest strength of each one — something most pages skip:
| Comparison | Type of evidence | How confident |
|---|---|---|
| Zepbound vs standard Wegovy | Direct head-to-head trial (SURMOUNT-5) | Highest — tested against each other |
| Wegovy HD vs Zepbound | Separate trials only | Strong, but no head-to-head exists yet |
| Wegovy pill vs Foundayo | Separate trials only | Useful, but not a direct comparison |
| Retatrutide vs everything | Phase 3 topline, investigational | A future signal — not a choice today |
The honest catch (read this before you pick)
We’ll be straight with you, because it actually makes the rest of this page easier to trust.
The strongest option, Zepbound, is a weekly shot — not a pill. If a needle is a dealbreaker for you, Zepbound isn’t your pick, and you should look at the Wegovy pill or Foundayo instead (both are further down, and both are real options). It’s also a brand-name medicine, so it isn’t cheap up front.
But here’s why that “flaw” is the whole point: that weekly shot is exactly what produced 20.2% average weight loss against standard Wegovy in the head-to-head SURMOUNT-5 trial (and 20.9% at the 15 mg dose in SURMOUNT-1) — more than any pill on the market. And the up-front price isn’t the real story either. If you have insurance, Ro’s coverage team fights to get the medication covered, and eligible commercially insured patients can pay as little as $25 a month for Zepbound through Lilly’s savings program — far less than the cash sticker price.
So if your real goal is the most weight loss backed by the strongest evidence, a weekly shot through a provider that handles your insurance is the most direct route there is.
Which GLP-1 causes the most weight loss?
Among the GLP-1s you can actually get in 2026, Zepbound and the new Wegovy HD produce the most weight loss — both land around 21% on average. Standard Wegovy comes in near 15%, the Wegovy pill around 17%, and Foundayo around 11–12%. Retatrutide beat them all in trials at about 28%, but it’s not available to buy.
Zepbound (tirzepatide): the strongest result you can start today
Zepbound is a once-weekly shot. It works on two gut-hormone targets at once — GLP-1 plus a second one called GIP (another hormone that helps control blood sugar and appetite). That double action is a big reason it tops the charts.
In Eli Lilly’s SURMOUNT-5 trial — the only head-to-head study against Wegovy, published in the New England Journal of Medicine — people on Zepbound lost an average of 20.2% of their body weight over 72 weeks, compared with 13.7% on standard Wegovy. That’s about 50 pounds versus 33. And nearly 1 in 3 Zepbound users (31.6%) lost a quarter of their body weight or more — the kind of result that used to take surgery.
A real-world study of more than 18,000 adults, published in JAMA Internal Medicine, showed the same pattern: tirzepatide users lost more at every checkpoint — about 5.9% at 3 months, 10.1% at 6 months, and 15.3% at 12 months — compared with 3.6%, 5.8%, and 8.3% for semaglutide.
Wegovy HD (semaglutide 7.2 mg): the new challenger
For years, 2.4 mg was the ceiling for Wegovy. Then the FDA approved Wegovy HD — a triple-strength 7.2 mg dose — on . In its STEP UP trial, people lost about 20.7% of their body weight over 72 weeks if they stayed on it (about 18.8% counting everyone, including people who stopped). Roughly 31% hit 25% or more.
That’s nearly identical to Zepbound. The catch: Wegovy HD is not a starting dose. You can only step up to it after you’ve handled standard Wegovy (2.4 mg) for at least four weeks. So if you’re brand-new, it’s probably not your fastest first move.
Standard Wegovy (semaglutide 2.4 mg): still a heavyweight
The original Wegovy shot produces about 15% average weight loss over 68 weeks — and Wegovy has a few things the others don’t. It’s the GLP-1 with proven protection against heart attack and stroke for adults with known heart disease, and the injectable form has FDA approval for use in some teens with obesity. Even though its number is lower, it’s still the right call for plenty of people.
Wegovy pill (oral semaglutide 25 mg): the strongest pill
If you want a pill, this is the strongest one by the data. The FDA approved the Wegovy pill in December 2025 — the first GLP-1 pill cleared for weight loss. In the OASIS-4 trial, people lost about 17% of their body weight in 64 weeks if they stayed on it (about 14% counting everyone), and 1 in 3 lost 20% or more.
One thing to know: oral semaglutide is fussy about timing. You take it on an empty stomach with a small sip of water, then wait 30 minutes before eating, drinking, or taking anything else. Miss that routine and it works less well.
Foundayo (orforglipron): the easy-to-take pill
Foundayo, approved by the FDA on , is a different kind of pill. It’s a small molecule, which means you can take it any time of day, with or without food — no fasting rules. In Lilly’s ATTAIN-1 trial, people on the top dose lost an average of about 27 pounds (around 11–12% of body weight) over 72 weeks.
It’s not the strongest option. But if a strict pill routine is the thing that would trip you up, “easy to take every day” can beat “stronger on paper but skipped half the time.”
Retatrutide: the strongest result — that you can’t buy
You may have seen headlines about retatrutide hitting bigger numbers than anything else. They’re real. In Lilly’s TRIUMPH-1 trial (announced May 2026), people on the top dose lost an average of 28.3% of their body weight in 80 weeks. That rivals surgery.
Is Zepbound faster than Wegovy for weight loss?
Against standard Wegovy, yes — Zepbound won the head-to-head clearly: 20.2% vs 13.7% over 72 weeks. But that does not mean Zepbound beats every Wegovy. The new Wegovy HD wasn’t in that trial, and it nearly matches Zepbound — so “Zepbound beats standard Wegovy” is true, while “Zepbound beats all Wegovy” is not proven.
This is the single most important thing to understand, and it’s where most articles are out of date.
When Zepbound is your fastest path:
- You want the strongest result
- You’re fine with a weekly shot
- You’re starting fresh
- No specific reason to need semaglutide
When Wegovy is still the better pick:
- You have known heart disease
- Insurance covers Wegovy but not Zepbound
- You’re already on Wegovy and doing fine
- The patient is a teen (Wegovy has FDA approval for adolescents)
If you’re torn between the two, the deciding factor is usually coverage, not the trial numbers. That’s a five-minute thing to check.
Is Wegovy HD the new fastest GLP-1?
Wegovy HD is one of the two strongest GLP-1s available — but it’s a “next step,” not a starting line. It’s designed for adults who already tolerated standard Wegovy (2.4 mg) for at least four weeks and need more weight loss. So it’s the fastest move for some current Wegovy users, not the fastest first choice for everyone.
If you’re already on Wegovy and stalling, this is a real conversation to have. The 7.2 mg dose pushed average weight loss to about 20.7% in the STEP UP trial, with roughly 31% of people losing a quarter of their body weight.
If you’re brand-new to GLP-1s, you can’t jump straight to Wegovy HD anyway. You’d start lower and step up. So for a fresh start, Zepbound is usually the more direct route to the biggest number.
Zepbound vs Wegovy HD: which is faster if you’re starting fresh?
If you’re starting fresh, Zepbound is usually the more direct fastest path. It can be started through normal dose titration and has the cleanest head-to-head win against standard Wegovy. Wegovy HD is a powerful next step, but it’s mainly for adults who already tolerated Wegovy 2.4 mg and need more.
Think of it this way. The two land in the same place on the scale — about 21% average loss. But Wegovy HD is a destination you reach after a few months on standard Wegovy, while Zepbound is a route you can start at the beginning. For a first-timer who wants the strongest result with the least detour, that makes Zepbound the simpler answer. For someone already on Wegovy who’s plateaued, Wegovy HD is the natural next gear.
What is the fastest GLP-1 pill for weight loss?
It depends on what “fastest” means to you. For the strongest pill data, it’s the Wegovy pill (~17%). For the easiest pill to take consistently, it’s Foundayo, because it has no food or timing rules. Both are FDA-approved. Neither matches the shots on raw numbers — that’s the honest trade-off of going needle-free.
| If you say… | The better pill to ask about |
|---|---|
| “I want the most weight-loss data in a pill.” | Wegovy pill (oral semaglutide) |
| “I can’t deal with strict empty-stomach rules.” | Foundayo |
| “I want the easiest daily routine.” | Foundayo |
| “I want the strongest option overall, pill or shot.” | Zepbound or Wegovy HD |
Why timing matters so much: real-world “speed” isn’t just the trial number — it’s whether you actually take the medicine the right way every day. The Wegovy pill is stronger on paper, but its empty-stomach, wait-30-minutes routine trips some people up. Foundayo is gentler on your schedule. The best pill is the one you’ll take correctly without resenting it.
How fast do GLP-1s actually work — and what’s a safe pace?
Many people notice their appetite drop within the first week or two, but real scale movement builds over months, not days. These medicines start at a low dose and step up on purpose, to keep side effects manageable.
| Time on treatment | What’s typical |
|---|---|
| Weeks 1–2 | Appetite and cravings often ease; you’re on the lowest starter dose; the scale may not move yet |
| 3 months | Real-world average around 6% lost on tirzepatide (about 3.6% on semaglutide) — enough to see a clear pattern |
| 6 months | Around 10% on tirzepatide (about 5.8% on semaglutide) |
| 12 months | Around 15% on tirzepatide (about 8.3% on semaglutide) |
Source: real-world JAMA Internal Medicine data. Your results will vary.
By around three months, most people can tell whether the plan is working — but no honest page can promise a specific result by a specific date. The CDC is clear: losing about 1 to 2 pounds a week is more likely to stay off than crash weight loss. Going faster than your body wants raises the odds of harsh nausea, muscle loss, and gallbladder problems. The smart play is to protect your muscle while you lose — eat enough protein and keep up some strength training — so the weight you drop is fat, not the muscle you’ll want later.
Watch for these red flags when you compare providers:
- Promises of extreme, rapid weight loss
- No real medical screening before they prescribe
- “Research” peptides or mystery “compounded” products with vague sourcing
- Hidden membership fees or no clear cancellation policy
- Prices that say “starting at” without telling you the full monthly cost
Who should NOT chase the fastest GLP-1?
The strongest option isn’t automatically the safest option for every person. Zepbound and Wegovy carry a boxed warning against use if you have a personal or family history of medullary thyroid cancer or a condition called MEN 2 — and a clinician needs to weigh several other factors before prescribing. This is exactly why a real medical review matters more than a fast checkout.
Talk to a clinician first — and likely look at a different path — if any of these apply:
- ⚠A personal or family history of medullary thyroid carcinoma (a specific thyroid cancer) or MEN 2 (Multiple Endocrine Neoplasia type 2, an inherited condition)
- ⚠A serious allergy to the medication’s ingredients
- ⚠You’re pregnant, planning a pregnancy, or breastfeeding
- ⚠A history of pancreatitis (inflammation of the pancreas) or gallbladder disease
- ⚠Severe stomach or gut problems, especially slowed stomach emptying (gastroparesis) or trouble digesting food
- ⚠A history of an eating disorder, or active food restriction
- ⚠You take a diabetes medicine that can cause low blood sugar, such as insulin or a sulfonylurea, or any medication whose absorption could change if your stomach empties more slowly
We’d rather tell you this option might be wrong for you than push you toward it. If any of the above is you, the right next step isn’t a provider link — it’s a few questions to figure out where you actually stand.
What’s the fastest legitimate way to get started?
For FDA-approved, brand-name GLP-1s, the fastest legitimate path is a telehealth provider that carries the medicine and handles your insurance. We’d start with Ro, and compare Sesame Care if you want more provider choice. Both connect you with a licensed clinician who decides if treatment is right for you — there’s no skipping the medical step, and that’s a good thing.
Ro — our first pick for fastest brand-name access
- ✓Carries all the FDA-approved options this page compares. Zepbound, the Wegovy shot, the Wegovy pill, and Foundayo are all available through Ro — so if your clinician switches you, you don’t have to change providers.
- ✓The insurance team does the hard part. Ro says its insurance concierge checks your coverage and handles the prior authorization paperwork, so your medication cost might just be your copay.
- ✓Transparent cash pricing. Ro matches the manufacturers’ direct cash prices. The Wegovy pill and Foundayo start at $149 for the first month.
- ✓Simple membership. Get started for $39 the first month, then as low as $74/month with an annual plan paid upfront. Medication billed separately.
One Ro patient on Trustpilot: “It only took 1 day for my healthcare provider to review my health record and prescribe my medication. My medication came in 2 days.” (A real Trustpilot review; one person’s experience, not a typical-results promise.) Read more in our Ro Body review (sponsored affiliate link, opens in a new tab).
Coverage limit to know: Medicare has generally not covered GLP-1s prescribed specifically for weight loss (a limited pilot is set to begin mid-2026), and Medicaid coverage varies by state. If you’re on a government plan, treat the cash prices here as your likely cost.
Sesame Care — our pick if you want provider choice
Sesame works more like a marketplace. You can see different clinicians, compare cash-pay prices up front, and it lists brand-name GLP-1s including the Wegovy pill, the Zepbound KwikPen, the Wegovy pen, and Foundayo. Its weight-loss program can start as low as $59/month with an annual plan. If shopping the provider — not just the medication — matters to you, it’s worth a look.
See how Sesame stacks up in our GLP-1 telehealth comparison →
Your own doctor counts too
Here’s where we’ll talk you out of a click if it’s the wrong one: Ro and Sesame aren’t automatically better than your own doctor. If you already have a clinician who knows your history, your insurance covers obesity medication, and your doctor will move the prior authorization quickly — that may be the cleanest path of all. Online providers shine when you don’t have that: when you need help checking coverage, comparing brand-name options, or just getting seen without a three-week wait.
How much do the fastest GLP-1 options cost without insurance?
Without insurance, brand-name GLP-1s usually run a few hundred dollars a month, and the number changes with your dose, the pharmacy, and any current savings offer. The most important thing to understand: the medication cost and the telehealth membership are two separate bills. A $39 first-month membership is not the cost of your medicine.
Membership / care fee
What you pay the telehealth provider for the visit, support, and coaching (e.g., Ro’s $39 first month).
Medication cost
What you pay the pharmacy for the drug itself, which depends on dose and insurance.
| Option | Cash price | Notes |
|---|---|---|
| Zepbound (KwikPen) | $299 first month, then $399–$449/mo | Lower-cost KwikPen format; higher prices may apply at other pharmacies |
| Wegovy pen | $199 first month, then $199–$399/mo | Promo on starter doses through June 30, 2026 |
| Wegovy HD | ~$399/mo | Per NovoCare’s listed price; only after tolerating standard Wegovy |
| Wegovy pill | $149 first month, then $199–$299/mo | Lower doses cost less |
| Foundayo | $149 first month, then $199–$299/mo | Lower doses cost less |
| Ro Body (sponsored affiliate link, opens in a new tab) membership | $39 first month | Then as low as $74/mo with annual prepay; medication separate |
What changes after the intro price:
- Starter-dose promo prices go up once you move to higher doses
- Savings offers can change or end
- Annual prepay lowers your monthly cost but means a bigger payment up front
- Insurance savings cards usually exclude people on Medicare or Medicaid
And here’s the move that beats every cash price: if you have insurance, check coverage first. Eligible commercially insured patients often pay around $25 a month for brand-name Zepbound or Wegovy under the manufacturers’ savings programs — far less than any cash deal. Don’t choose based on the sticker price until you know what your plan will do.
See our full guide: best GLP-1 with an active savings card 2026 →
What about Ozempic, Mounjaro, compounded GLP-1s, and “research” retatrutide?
For fastest weight loss, the right answers are the FDA-approved weight-loss medicines above — not diabetes-only brands, not compounded copies, and not investigational drugs.
Ozempic and Mounjaro
Ozempic and Mounjaro are diabetes medications. Ozempic contains semaglutide — the same active ingredient as Wegovy — and Mounjaro contains tirzepatide — the same active ingredient as Zepbound. The difference is the FDA-approved use: Wegovy and Zepbound are the brands cleared specifically for chronic weight management, with their own labels and dosing.
Compounded GLP-1s
You’ll see compounded semaglutide and tirzepatide advertised at low prices. We’re not leading you there on this page, and here’s the honest reason: compounded medications are not FDA-approved. A compounded drug is mixed by a pharmacy rather than made by the brand manufacturer, and it hasn’t gone through the FDA’s review for safety, effectiveness, and quality. The strong trial results on this page come from the brand-name products — they don’t automatically apply to a compounded version.
Retatrutide
Strongest trial numbers, not a real option yet. Retatrutide isn’t FDA-approved, and the only legal access is a clinical trial. Anything labeled “research retatrutide” for sale online is unapproved and unregulated. Skip it.
Not sure which path fits you? Take the 60-second quiz
An online article can tell you “Zepbound usually produces more weight loss.” It can’t tell you what fits your situation. Our free matching quiz can. Answer a few quick questions — shot or pill, whether you already take Wegovy, insurance or cash-pay, strongest result or easiest routine — and you’ll get a personalized action plan.
Get your personalized action plan — which medication to ask about, which path fits your insurance, and exactly what to do next.
How we ranked the fastest GLP-1 options
We ranked these by how much weight each medicine produced in its clinical trial, whether a new patient can actually start it, its FDA-approved status for weight loss, its price, and how easy it is to take. This is an editorial comparison from The RX Index, a pricing intelligence and comparison resource for GLP-1 telehealth providers — not medical advice, and not a promise about your personal result.
Trial numbers and FDA status come from primary sources — the manufacturers’ published results, the New England Journal of Medicine, The Lancet Diabetes & Endocrinology, and FDA materials. Provider and price details come straight from the providers’ own pages.
What we verified on :
- Zepbound’s head-to-head result vs standard Wegovy (SURMOUNT-5, New England Journal of Medicine; Eli Lilly)
- Wegovy HD’s approval (March 19, 2026), STEP UP results, and the dysesthesia side-effect rates (Novo Nordisk; The Lancet Diabetes & Endocrinology)
- The Wegovy pill’s FDA approval (December 2025) and OASIS-4 result (Novo Nordisk)
- Foundayo’s FDA approval (April 1, 2026), its any-time-with-or-without-food dosing, and its price range (Eli Lilly; Ro)
- Retatrutide’s TRIUMPH-1 result and investigational status (Eli Lilly)
- Real-world weight-loss-over-time data for tirzepatide vs semaglutide (JAMA Internal Medicine)
- Ro’s membership pricing, GLP-1 lineup, and insurance support (Ro)
- The CDC’s healthy-weight-loss guidance, and the FDA’s warning about unapproved GLP-1 products
Prices and availability change. We re-verify this page monthly and update the date at the top.
Real reviews: what people care about before choosing
People searching for the fastest GLP-1 aren’t only comparing trial numbers — they’re worried about speed, cost surprises, insurance headaches, and whether a program feels legit. We use reviews to show what the experience is like, never to prove a medicine works or to promise a result.
What people praise
Responsive care and insurance help. As one Ro member put it: “The care and communication has been second to none. The results I have seen since beginning Zepbound have given me a new sense of confidence and happiness that I did not know that I was missing.” (Ro published this testimonial and discloses that featured members were compensated — treat it as one person’s experience, not a typical result.)
What people complain about
Price clarity. The gripe we saw most often wasn’t the medicine — it was billing surprises, where someone expected one charge and got hit with both a medication bill and a separate membership fee. That’s the exact reason this page splits medication cost from membership cost and calls out “starting at” pricing.
Frequently asked questions
What is the best GLP-1 for fastest weight loss?
For most people starting fresh, Zepbound (tirzepatide) is the best GLP-1 for fastest weight loss, because it had the strongest head-to-head result against standard Wegovy — about 20% weight loss versus 14% over 72 weeks. The answer changes if you want a pill, already take Wegovy, have specific insurance coverage, or have a medical reason to avoid tirzepatide.
Which GLP-1 causes the most weight loss?
Among options you can get today, Zepbound and Wegovy HD produce the most, both around 21% on average. The Wegovy pill is about 17%, standard Wegovy about 15%, and Foundayo about 11–12%. Retatrutide produced about 28% in trials but isn’t available to buy.
Is Zepbound faster than Wegovy?
Against standard Wegovy, yes — Zepbound produced 20.2% weight loss versus 13.7% in the SURMOUNT-5 head-to-head trial. That comparison doesn’t prove Zepbound beats the newer Wegovy HD, which nearly matches it and wasn’t part of that trial.
Is Wegovy HD better than Zepbound?
They’re roughly tied at the top, and there’s no head-to-head comparing them yet. Wegovy HD is mainly for people already on standard Wegovy who need more, not a starting dose for new patients.
What is the fastest GLP-1 pill?
The Wegovy pill (oral semaglutide) has the stronger weight-loss data at about 17%, but it has strict empty-stomach dosing rules. Foundayo is easier to take — any time of day, with or without food — but produces less weight loss on average.
How much weight will I lose in the first month?
There’s no guaranteed first-month number. GLP-1s start at low doses and step up gradually, so clear scale changes usually build over the first few months. The CDC notes that steady loss of about 1 to 2 pounds a week is more likely to stay off than faster loss.
Is it safe to lose weight this fast?
Faster isn’t automatically safer. Rapid loss raises the risk of nausea, muscle loss, and gallbladder problems, which is why these medicines are titrated up slowly and need medical supervision. Protecting muscle with enough protein and strength training helps.
Is retatrutide available?
No. Retatrutide has strong trial data but is investigational and only available through clinical trials. Don’t buy “research” retatrutide products sold online.
Are compounded GLP-1s the fastest option?
We don’t frame compounded GLP-1s as the fastest option, because compounded medications are not FDA-approved and haven’t gone through the FDA’s review for safety, effectiveness, and quality. The strong trial results on this page come from the brand-name products.
Is Ozempic approved for weight loss?
No — Ozempic is approved for type 2 diabetes. It contains semaglutide, the same active ingredient as Wegovy, but Wegovy is the brand approved specifically for chronic weight management. Likewise, Zepbound contains tirzepatide, the same active ingredient as Mounjaro, but Zepbound is the brand approved for weight management.
Which provider should I use to start?
For FDA-approved brand-name GLP-1s, start with Ro if you want insurance support and coverage checking, and compare Sesame Care if you want to choose among different clinicians. Both require a licensed clinician to approve treatment.
Still not sure which GLP-1 program is right for you?
Take the free 60-second GLP-1 matching quiz →We’ll ask a few simple questions and hand you a personalized action plan — which medication to ask about, which path fits your insurance, and exactly what to do next.
This article is for general information and isn’t medical advice. GLP-1 medications are prescription drugs with real risks and benefits. Talk with a licensed clinician about what’s right for you. Individual results vary.